The mid-Atlantic region is a hotbed of the American biotechnology industry, with several major medical schools, numerous research universities and colleges, many established companies in the pharmaceutical, medical device, and diagnostics industries, and an ever-increasing number of startup entities. Being home to so diverse an array of professionals, the Philly region also attracts the attention of entities that interact with biotechnology professionals and their organizations.

Throughout its history, Dilworth Paxson has represented companies and individuals involved in the biotechnology industry. Reflecting the interplay of science, business, and law that characterizes the biotech industry, Dilworth Paxson ranks include individuals trained as scientists, business persons and, of course, lawyers. Our attorneys work together as needed to address issues faced by clients in this field – and to help our clients anticipate and address new concerns as they arise.

Our firm’s diversity of lawyers knowledgeable in biotechnology enables us to assemble teams of advisors capable of assisting our biotech clients with the variety of issues with which they find themselves confronted and to readily and seamlessly alter those teams as the scope and nature of the issues change. Our firm includes patent attorneys having extensive training in biotechnical fields, lawyers specializing in corporate issues faced by existing and start-up companies, attorneys who advise investors and collaborators seeking to work with biotech companies, and litigators who have represented biotechs before relevant courts and tribunals.

Examples of assistance we provide to clients in the biotechnology industry include:

  • General corporate representation, including entity formation, real estate, employment, and tax advice;
  • Creation, procurement, and enforcement of intellectual property, such as patents, trade secrets, and trademarks;
  • Negotiation, investigation, and execution of corporate transactions, such as asset transfers, mergers and acquisitions, financing and collaboration agreements, and bankruptcies;
  • Advice regarding compliance with state, Federal, and health insurance industry requirements for contracting and reimbursement in the health care industries; and
  • Representation before state and federal courts and before government administrative bodies, in litigation matters such as intellectual property and employment disputes, enforcement of non-disclosure and non-compete agreements, resolution of commercial and contract disputes, appeals, and interferences within the U.S. Patent Office, financial regulatory filings, and bankruptcy matters.